Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.
about
Development of Human Membrane Transporters: Drug Disposition and PharmacogeneticsInter-individual variation in midazolam clearance in children.Inter-individual variation in morphine clearance in children.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenTowards Rational Dosing Algorithms for Vancomycin in Neonates and Infants Based on Population Pharmacokinetic Modeling.Dosage individualization in children: integration of pharmacometrics in clinical practice.Ethics of drug research in the pediatric intensive care unit.Impact of special patient populations on the pharmacokinetics of echinocandins.Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonatesPharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Therapeutic drug monitoring in neonates.Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis.Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.Clinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.Pediatric pharmacology: current efforts and future goals to improve clinical practice.Population pharmacokinetics of intravenous clonidine for sedation during paediatric extracorporeal membrane oxygenation and continuous venovenous hemofiltration.Advanced Boolean modeling of biological networks applied to systems pharmacology.Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey.Frequency-Domain Response Analysis for Quantitative Systems Pharmacology Models.Population pharmacokinetic modeling of Thymoglobulin(®) in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing.
P2860
Q26786582-DF31EBC6-98DF-4415-A9B5-67155E5B4A90Q35301181-9CF8F355-E4DF-4558-91F5-80B0E0B695B6Q35595573-E48AD5AF-345A-48D2-B142-52DDC811DA21Q36322918-7D9EFFB8-5529-4E7A-A183-C0FF24DCE2D2Q36571794-D1E5DF6E-AA84-4D64-B488-EAD18F9D7787Q38240055-B48D9033-610D-49C6-AC2C-792F9C83A42DQ38263726-860C098F-F247-4878-ABED-D42AA5322DCFQ38462784-6D3DF64B-E850-4AF9-830E-40415A2346C3Q38657914-413E0A66-A9BC-49ED-A06E-823EA952CFB7Q38696468-FC448C72-CF0F-4AD0-909D-190D8D3E9E50Q38709104-C32F947B-7A79-4EFA-9625-E31F364AC98DQ38771392-36663597-D548-4A4F-B40D-EBB935BCCF01Q38857191-0BBE2A3F-6609-4A00-96A8-E9B2E3E7A07DQ38882590-84D3C2AA-F84A-47DB-BD5E-DC60551A3AEBQ38897538-40E0C51B-C128-46BE-A4FF-962E1DD04329Q38985619-EB037EED-94B0-45FC-B3D3-6EE267124959Q39025601-39F7185C-B302-43F5-AE29-08CCAF3CFFD7Q39028504-CE48EABC-6BC2-457E-862D-85BFC938DA87Q41516160-72B0AC0B-572B-440C-864E-21F18513232FQ47295403-7BD90FFE-455A-4A9A-83A8-D1800FA41FEBQ51000653-A65F016A-9C59-42F2-A260-189A5CDA6D0A
P2860
Towards evidence-based dosing regimens in children on the basis of population pharmacokinetic pharmacodynamic modelling.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@ast
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@en
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@nl
type
label
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@ast
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@en
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@nl
prefLabel
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@ast
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@en
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@nl
P2093
P2860
P1476
Towards evidence-based dosing ...... tic pharmacodynamic modelling.
@en
P2093
Catherijne A J Knibbe
Charlotte van Kesteren
Rick Admiraal
Robbert G M Bredius
P2860
P304
P356
10.1136/ARCHDISCHILD-2013-303721
P407
P577
2013-12-19T00:00:00Z